GE Healthcare

 
GE Healthcare Life Sciences Part of GE Healthcare
  
items: total: checkout
On-line Ordering
Catalog Home
Quick Order Form
Shopping Cart
Returns
Online ordering overview
Frequently Asked Questions
Last updated:09/02/2010

VIIISelect

  • Highly selective to recombinant b-domain depleted Factor VIII
  • Efficient purification of recombinant b-domain depleted Factor VIII with high yields and retained activity
  • Excellent scalability
  • Non-animal derived
Page down for more information

BioProcess media. Process-scale quantities are available.

VIIISelect

Technical Information


VIIISelect is an affinity medium designed for the purification of recombinant b-domain depleted factor VIII, a key recombinant blood factor used for treatment of Hemophilia A. Due to the sensitive nature of the factor VIII molecule it is important to limit the number of steps in the downstream process. The high selectivity and yields obtained using VIIISelect enable a robust and efficient purification process with excellent purity obtained in one step.

TECHNICAL SPECIFICATIONS
Composition Highly crosslinked agarose 
Particle size 75 µm average (d50, vol) 
Ligand 13 kD recombinant protein produced in S. cerevisiae. Binds to b-domain depleted factor VIII molecules. 
Coupling chemistry NHS 
Pressure/flow spec At least 300 cm/hour in a BPG 300 column with 20 cm bed height at less than 2 bars 



Feedback Form